M

Matricelf Ltd
TASE:MTLF

Watchlist Manager
Matricelf Ltd
TASE:MTLF
Watchlist
Price: 522.9 ILS -0.83% Market Closed
Market Cap: 143.7m ILS

Matricelf Ltd
Investor Relations

Matricelf Ltd. engages in research and development of technology in the field of regenerative medicine. The firm operates in the field of tissue engineering and regenerative medicine. The Firm develops a platform for autologous 3D printing of neutral human matrix, cells, tissues and organs implants. The implants are manufactured using cellular components originated from the patients themselves, to reduce potential immune response. The firm focuses on the treatment of spinal cord injury (SCI), but is also involved in developing treatment for additional medical conditions, including: Myocardial Infarction (MI), Parkinson’s disease and Age-related Macular Degeneration (AMD). Matricelf Ltd is a spin-out company from Tel Aviv University.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Alon Sinai
Founder, CEO & Director
No Bio Available
Prof. Tal Dvir Ph.D.
Co-Founder, CSO & Director
No Bio Available
Ms. Sigal Russo-Gueta
Chief Financial Officer
No Bio Available
Tal Ben Neriah
VP of Operations
No Bio Available

Contacts

Address
Ness Ziona
Golda M'eir 3
Contacts
+972504057353
matricelf.com